Sanjiv.Parant.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE860D01013
  • NSEID:
  • BSEID: 531569
INR
194.90
1.8 (0.93%)
BSENSE

Feb 27

BSE+NSE Vol: 1.47 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 328426,
    "name": "Sanjiv.Parant.",
    "stock_name": "Sanjiv.Parant.",
    "full_name": "Sanjivani Paranteral Ltd",
    "name_url": "stocks-analysis/sanjivparant",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "194.90",
    "chg": 1.8,
    "chgp": "0.93%",
    "dir": 1,
    "prev_price": "193.10",
    "mcapval": "242.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531569,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE860D01013",
    "curr_date": "Feb 27",
    "curr_time": "",
    "bse_nse_vol": "1.47 k",
    "exc_status": "Active",
    "traded_date": "Feb 27, 2026",
    "traded_date_str": "2026 02 27",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sanjivparant-328426-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sanjivani Paranteral Ltd Falls 6.96%: Valuation Shifts and Rating Upgrade Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-falls-696-valuation-shifts-and-rating-upgrade-shape-the-week-3850045",
        "imagepath": "",
        "date": "2026-02-21 17:14:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Feb:</strong> Stock opens at Rs.207.55, down 1.40% despite Sensex rising 0.70%</p>\n                    <p><strong>17 Feb:</strong> Upgrade to Hold rating announced; stock drops 5.25% to Rs.196.65</p>\n                    <p><strong>18 Feb:</strong> Continued price decline to Rs.195.50 amid positive Sensex movement</p>\n                    <p><strong>19 Feb:</strong> Stock stabilises at Rs.195.35 despite Sensex falling 1.45%</p>\n                    <p><strong>20 Feb:</strong> Slight recovery to Rs.195.85 as Sensex gains 0.41%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div cl..."
      },
      {
        "title": "Sanjivani Paranteral Ltd Upgraded to Hold on Improved Financial and Technical Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-upgraded-to-hold-on-improved-financial-and-technical-metrics-3843460",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SanjivaniParant_mojoScore_3843460.png",
        "date": "2026-02-17 08:03:45",
        "description": "Sanjivani Paranteral Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements in its financial performance, valuation metrics, and technical outlook. The pharmaceutical and biotechnology company’s recent quarterly results and evolving market dynamics have prompted a reassessment of its quality, valuation, financial trend, and technical parameters, leading to a more favourable stance by analysts."
      },
      {
        "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-changing-market-sentiment-3843220",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SanjivaniParant_valuationdot_3843220.png",
        "date": "2026-02-17 08:01:17",
        "description": "Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating, reflecting a subtle improvement in price attractiveness. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer benchmarks within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Are Sanjivani Paranteral Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sanjivani-paranteral-ltd-latest-results-good-or-bad-3837969",
        "imagepath": "",
        "date": "2026-02-13 19:34:36",
        "description": "Sanjivani Paranteral Ltd's latest financial results for the quarter ended September 2025 reveal a continuation of operational challenges, marked by significant revenue contraction and declining profitability metrics. The company reported net sales of ₹15.50 crores, which reflects a year-on-year decline of 14.51% and a sequential decrease of 13.36%, representing the lowest revenue performance in seven quarters. This decline raises concerns about demand sustainability and competitive positioning in its export markets.\n\nIn terms of profitability, the net profit for the quarter was ₹1.64 crores, down 28.70% from the previous year, with the net profit margin contracting to 10.58%. Operating profit before depreciation, interest, tax, and other income (PBDIT) was ₹2.25 crores, indicating a year-on-year decline of 21.33%. The operating margin also compressed to 14.52%, down from 15.77% in the same quarter last year..."
      },
      {
        "title": "Sanjivani Paranteral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-sell-3824213",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SanjivaniParant_mojoScore_3824213.png",
        "date": "2026-02-06 10:10:03",
        "description": "Sanjivani Paranteral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "When is the next results date for Sanjivani Paranteral Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sanjivani-paranteral-ltd-3823075",
        "imagepath": "",
        "date": "2026-02-05 23:16:50",
        "description": "The next results date for Sanjivani Paranteral Ltd is scheduled for 13 February 2026...."
      },
      {
        "title": "Sanjivani Paranteral Ltd Falls to 52-Week Low of Rs.161 Amid Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-falls-to-52-week-low-of-rs161-amid-market-underperformance-3818805",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SanjivaniParant_priceRelatedfactors_3818805.png",
        "date": "2026-02-03 16:12:30",
        "description": "Sanjivani Paranteral Ltd’s shares declined sharply to a fresh 52-week low of Rs.161 on 3 February 2026, marking a significant downturn amid a broader market rally. The stock has underperformed its sector and the wider market, reflecting a series of financial and valuation concerns that have weighed on investor sentiment."
      },
      {
        "title": "Sanjivani Paranteral Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-falls-to-52-week-low-amidst-continued-downtrend-3816444",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SanjivaniParant_priceRelatedfactors_3816444.png",
        "date": "2026-02-02 11:18:20",
        "description": "Sanjivani Paranteral Ltd’s shares declined sharply to a fresh 52-week low of Rs.162.1 on 2 Feb 2026, marking a significant downturn amid broader market pressures and company-specific performance factors. The stock has now recorded a three-day consecutive fall, cumulatively losing 4.74% over this period, underperforming its sector and the broader market indices."
      },
      {
        "title": "Sanjivani Paranteral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-sell-3804701",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SanjivaniParant_mojoScore_3804701.png",
        "date": "2026-01-26 10:10:05",
        "description": "Sanjivani Paranteral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 January 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 195,
    "sid": "328426",
    "stock_news_url": "https://www.marketsmojo.com/news/sanjivani-paranteral-328426"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "18-Feb-2026",
      "details": "Easnings call Transcript date 16th February 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "17-Feb-2026",
      "details": "Outcome of the Investors & Analysts for Q3 FY26 Results",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
      "datetime": "16-Feb-2026",
      "details": "Revised Press Relase for the Quarter ended 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sanjivani Paranteral Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Sanjivani Paranteral Ltd Falls 6.96%: Valuation Shifts and Rating Upgrade Shape the Week

2026-02-21 17:14:57

Key Events This Week

16 Feb: Stock opens at Rs.207.55, down 1.40% despite Sensex rising 0.70%

17 Feb: Upgrade to Hold rating announced; stock drops 5.25% to Rs.196.65

18 Feb: Continued price decline to Rs.195.50 amid positive Sensex movement

19 Feb: Stock stabilises at Rs.195.35 despite Sensex falling 1.45%

20 Feb: Slight recovery to Rs.195.85 as Sensex gains 0.41%

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

18-Feb-2026 | Source : BSE

Easnings call Transcript date 16th February 2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

17-Feb-2026 | Source : BSE

Outcome of the Investors & Analysts for Q3 FY26 Results

Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

16-Feb-2026 | Source : BSE

Revised Press Relase for the Quarter ended 31st December 2025

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Sanjivani Paranteral Ltd has declared 5% dividend, ex-date: 19 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available